Consultation responses

• Pharmacy Voice responds to Monitor’s consultation on draft enforcement guidance
• Pharmacy Voice has responded to the MHRA’s draft 2013-18 corporate plan.
• Pharmacy Voice responds to Department of Health’s consultation on strengthening the NHS constitution
• Response to the consultation ‘Draft Regulations: the Controlled Drugs
• Response to the MLX 379 consultation on the Falsified Medicines Directive
• Response to consultation on on preventing sharp Injuries in the hospital and healthcare sector
• Pharmacy Voice responds to Department of Health’s consultation Securing best value for NHS patients
• Pharmacy Voice responds to Monitor’s consultation ‘The new NHS provider licence’
• Response to ‘Protecting & promoting patients’ interests – licensing providers of NHS services’
• Pharmacy Voice responds to ‘Our NHS care objectives – A draft mandate to the NHS Commissioning Board
• Community pharmacy: delivering improved outcomes for patients in the new NHS in England
• Pharmacy Voice responds to MHRA’s consultation on changing legal classification of medicines in UK
• Pharmacy Voice responds to shared decisions consultation
• Community pharmacy submission to the Information Governance Review
• Pharmacy Voice responds to ‘Enablers and barriers to integrated care and implications for Monitor
• Pharmacy Voice responds to Monitor’s preliminary consultation Fair Playing Field
• Pharmacy Voice responds to DoH’s consultation on a workforce strategy for public health
• Pharmacy Voice responds to consultation on Health and Wellbeing Boards
• Pharmacy Voice responds to GMC’s good medical practice explanatory guidance
• Pharmacy Voice responds to GPhC’s consultation on the draft 2012 fees rules
• Pharmacy Voice responds to GPhC’s consultation on modernising pharmacy regulation
• Pharmacy Voice responds to European Commission’s consultation on Falsified Medicines Directive
• Monitor stakeholder engagement: NHS Licence (tranche 2)
• Draft Joint Strategic Needs Assessment and joint health and wellbeing strategy guidance
• The Changing NHS and Public Health Landscape
• Pharmacy Voice response to NICE guidance on preventing type 2 diabetes
• Response to RPS professional standards for the use of monitored dosage systems and compliance aids
• Consultation response to the Open Public Services White Paper
• Consultation response on GPhC Equality Scheme
• Consultation response on proposed changes to regulations for Care Quality Commission registration
• Pharmacy Voice, PSNC and RPS respond to ‘A review of the procurement of seasonal flu vaccine’
• Pharmacy Voice submission to the Health Committee Public Health Inquiry
• UK Influenza Pandemic Preparedness Strategy response
• Building recovery in communities: Consultation on framework to replace models of care
• GPhC consultation on education related fees for 2012
• Tobacco Control Strategy for Northern Ireland
• Request to reclassify a product from POM to P Consultation Arm 75 Voltarol Pain-eze
• Liberating the NHS: Developing the healthcare workforce consulation
• Healthy Lives Healthy People funding and commission routes response
• Healthy Lives Healthy People strategy consultation response
• Healthy Lives Healthy People transparency of outcomes consultation response
• PV response to DoH on a new value based approach to pricing of branded medicines
• Pharmacy Voice response to DH Business Plan transparency framework
• Pharmacy Voice responds to GPhC new accreditation methodology
• Pharmacy Voice responds to consultation on GPhC CPD framework and rules
• Pharmacy Voice responds to consultation on GPhC standards for education and training of pharmacists
• Department of Health Liberating the NHS; Greater Choice and Control
• Department of Health an Information Revolution: A Consultation on Proposals
• Royal Pharmaceutical Society Draft Regulations and Schedules